Bupa enhances cancer coverage
by Richard Kilner
Story link: Bupa enhances cancer coverage
International healthcare group Bupa has announced that it has enhanced its provision of cancer coverage by no longer selling corporate health insurance schemes which include overall cost or time limits for the disease.
New drugs introduced several years ago steeply increased the cost of cancer treatment which led to financial and time limits being imposed.
Since then, however, it has been shown that such limits can leave patients vulnerable at critical moments in treatment and that patients often cannot know the full cost of treatment when a programme begins.
Bupa Health and Wellbeing MD Dr Natalie-Jane Macdonald explained that the firm had developed better and fairer means of controlling healthcare costs.
Figures from Cancer Research UK show that, in the UK, over 150,000 people die of cancer each year (2008), accounting for over a quarter (27%) of all annual deaths.